• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Nektar Therapeutics (NKTR)

    -NasdaqGS
    11.78 Up 0.30(2.61%) Jun 2, 4:00PM EDT
    |After Hours : 11.78 0.00 (0.00%) Jun 2, 4:32PM EDT
    Add to Portfolio
    Prev Close:11.48
    Open:11.45
    Bid:10.01 x 100
    Ask:11.96 x 300
    1y Target Est:16.25
    Beta:1.45
    Earnings Date:Jul 29 - Aug 3 (Est.)
    Day's Range:11.45 - 12.16
    52wk Range:9.51 - 17.53
    Volume:1,840,516
    Avg Vol (3m):1,733,800
    Market Cap:1.55B
    P/E (ttm):59.49
    EPS (ttm):0.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NKTR

    Comparison

    Symbol% ChgMkt Cap
    NKTRUp 2.61%1.55B
    BMYDown 1.02%109.69B
    ENZNDown 3.33%57.66M
    GSKUp 0.20%106.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.21
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Jun-15) :-0.31
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):2.97

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Nektar Therapeutics, a biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback